Survey of the prevalence of βlactamases amongst 1000 gram-negative bacilli isolated consecutively at the royal london hospital

Journal of Antimicrobial Chemotherapy

Volumn 30, Issue 4, 1992, Pages 429-447

  Liu, P Y F ^a   Gur, Deniz ^a   Hall, Lucinda M C ^a   Livermore, D M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CARBENICILLIN; CEFALORIDINE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLAVULANIC ACID; IMIPENEM; NITROCEFIN; PENICILLIN G; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TEMOCILLIN; TICARCILLIN; TIMENTIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BLOOD CULTURE; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PLASMID; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA; SPUTUM CULTURE; URINE CULTURE; WOUND;

ANTIBIOTICS; BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; HUMAN; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026445738     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/30.4.429     Document Type: Article

References (42)

1. Amicosante, G., Marinucd, M. C., Franceschini, N., Tizzani, M. I., Oliva, B. and Oratore, A. (1987). Fractionation and characterization of two β-lactamases in Citrobacter diversus ULA-27 strain by chromatofocusing. Journal of Chromatography 403, 366-72.
2. Arakawa, Y., Ohta, M., Kido, N., Mori, M., Ito, H., Komatsu, T. et al. (1989). Chromosomal /Mactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum /Mactam antibiotics. Antimicrobial Agents and Chemotherapy 33, 63-70.
3. Ayling-Smith, B. and Pitt, T. L. (1990). State of the art in typing. Klebsiella spp. Journal of Hospital Infection 16, 287-95.
4. Bobrowski, M. M., Matthew, M., Barth, P. T., Datta, N., Grinter, N. J., Jacob, A. E. et al. (1976). Plasmid-determined /Mactamase indistinguishable from the chromosomal /Mactamase of Escherichia coli. Journal of Bacteriology 125, 149-57.
5. Bush, K. (1989). Classification of β-lactamases: groups 2c, 2d, 2e, 3 and 4. Antimicrobial Agents and Chemotherapy 33, 271-6.
6. Coetzee, J. N., Datta, N. and Hedges, R. W. (1972). R-factors fram Proteus rettgeri. Journal of General Microbiology 15, 543-52.
7. Ewing, W. H. (1986). Edwards and Ewings' Identification of Enterobacteriaceae, 4th edn, pp. 528-9. Elsevier, New York.
8. Gaston, M. A., Ayling-Smith, B. A. and Pitt, T. L. (1987). New bacteriophage typing scheme for subdivision of the frequent capsular serotypes of Klebsiella spp. Journal of Clinical Microbiology 25, 1228-32.
9. Hall, L. M. C., Duke, B., Guiney, M. and Williams, R. (1992). Typing of Enterococcus species by DNA restriction fragment analysis. Journal of Clinical Microbiology 30, 915-9.
10. Hood, J. and Amyes, S. G. B. (1991). The chromosomal β-lactamases of the genus Acinetobacter: enzymes which challenge our imagination. In The Biology of Acinetobacter: Taxonomy, Clinical Importance, Molecular Biology, Physiology, Industrial Relevance (Towner, K. J., Bergogne-Berezin, E. and Fewson, C. A., Eds), pp. 117-32. Plenum Press, New York.
11. Jacoby, G. A. and Medeiros, A. A. (1991). More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 35, 1697-704.
12. Joly-Guillou, M. L., Bergogne-Berezin, E. and Vieu, J. F. (1991). Epidemiology of Acinetobacter strains isolated from nosocomial infections in France. In The Biology of Acinetobacter: Taxonomy, Clinical Importance, Molecular Biology, Physiology, Industrial Relevance (Towner, K. J., Bergogne-Berezin, E. and Fewson, C. A., Eds), pp. 63-8. Plenum Press, New York.
13. Kado, C. I. and Liu, S. T. (1981). Rapid procedure for detection and isolation of large and small plasmids. Journal of Bacteriology 145, 1365-73.
14. Livermore, D. M. (1987). Clinical significance of 0-lactamase induction and stable derepression in Gram-negative rods. European Journal of Clinical Microbiology 6, 439-45.
15. Matthew, M. (1979). Plasmid-mediated 0-lactamases of Gram-negative bacteria: properties and distribution. Journal of Antimicrobial Chemotherapy 5, 349-58.
16. Matthew, M. and Harris, A. M. (1976). Identification of beta-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. Journal of General Microbiology 94, 55-67.
17. Matthew, M., Harris, A. M., Marshall, M. J. and Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of 0-lactamases. Journal of General Microbiology 88, 169-78.
18. Medeiros, A. A. (1984). 0-Lactamases. British Medical Bulletin 40, 18-27.
19. Merrier, J. and Levesque, R. C. (1990). Cloning of SHV-2, OHIO-1, and OXA-6 β-lactamases and cloning and sequencing of SHV-1 β-lactamase. Antimicrobial Agents and Chemotherapy 34, 1577-83.
20. Orskov, I. and Orskov, F. (1984). Serotyping of Klebsiella. In Methods in Microbiology, Vol. 14 (Bergan, T., Ed.), pp. 143-64. Academic Press, London.
21. Palfreyman, J. M. (1978). Klebsiella serotyping by counter-current immunoelectrophoresis. Journal of Hygiene 81, 219-25.
22. Papanicolaou, G. A., Medeiros, A. A. and Jacoby, G. A. (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 34, 2200-9.
23. Philippon, A., Labia, R. and Jacoby, G. (1989). Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 33, 1131-6.
24. Pitcher, D. G., Saunders, N. A. and Owen, R. J. (1989). Rapid extraction of bacterial genomeic DNA with guanidium thiocyanate. Letters in Applied Microbiology 8, 151-6.
25. Quinn, J. P., Miyashiro, D., Sahm, D., Flamm, R. and Bush, K. (1989). Novel plasmid-mediated 0-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 33, 1451-6.
26. Roy, C., Foz, A., Segura, C., Tirado, M., Fuster, C. and Reig, R. (1983). Plasmid-determined 0- lactamases identified in a group of 204 ampirillin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 12, 507-10.
27. Roy, C., Segura, C., Tirado, M., Reig, R., Hermida, M., Teruel, D. et al. (1985). Frequency of plasmid-mediated beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae. European Journal of Clinical Microbiology 4, 146-7.
28. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd edn. 3 vols. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Sanders, C. C. and Sanders, W. E. (1987). Clinical importance of inducible beta-lactamases in Gram-negative bacteria. European Journal of Clinical Microbiology 6, 435-8.
30. Seetulsingh, P. S., Hall, L. M. C. and Livermore, D. M. (1991). Activity of clavulanate combinations against TEM-β-lactamase-produring Escherichia coli isolates obtained in 1982 and 1989. Journal of Antimicrobial Chemotherapy 27, 749-59.
31. Shah, P. M., Asanger, R. and Kahan, F. M. (1991). Incidence of multi-resistance in Gram-negative aerobes from intensive care units of ten German hospitals. Scandinavian Journal of Infectious Diseases, Suppl. 78, 22-34.
32. Simpson, I. N., Harper, P. B. and O’Callaghan, C. H. (1980). Principal β-lactamases responsible for insistence to β-lactam antibiotics in urinary tract infections. Antimicrobial Agents and Chemotherapy 17, 929-36.
33. Simpson, I. N., Knothe, H., Plested, S. J. and Harper, P. B. (1986). Qualitative and quantitative aspects of β-lactamase production as mechanisms of /Mactara resistance in a survey of clinical isolates from faecal samples. Journal of Antimicrobial Chemotherapy 17, 725-37.
34. Snydman, D. R. (1991). Clinical implications of multi-drug resistance in the intensive care unit Scandinavian Journal of Infectious Diseases, Suppl. 78, 54-63.
35. Stobberingh, E. E., Houben, A. W. and Van Boven, C. P. A. (1982). Distribution and characterization of β-lactamase-producing strains isolated in the southern part of the Netherlands. In Current Chemotherapy and Immunotherapy: Proceedings of the 12th International Congress of Chemotherapy, Florence, 1981, Vol. 1, (Periti, P. and Grassi, G. G., Eds), pp. 747-8. American Society for Microbiology, Washington, DC.
36. Sykes, R. B. and Matthew, M. (1976). The β-lactamases of Gram-negative bacteria and their role in resistance to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 2, 115-57.
37. Tzelepi, E., Tzouvelekis, L. S., Vatapoulos, A. C., Mentis, A. F., Tsakrif, A. and Legalds, N. J. (1992). High prevalence of stably derepressed Class C β-lactamases in multi resistant Enterobacter cloacae. Journal of Medical Microbiology, in press.
38. Verbist, L. (1991). Incidence of multi-resistance in Gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study. Scandinavian Journal of Infectious Diseases, Suppl. 78, 45-53.
39. Whitaker, S., Hajipieris, P. and Williams, J. D. (1983). Distribution and type of beta-lactamase amongst 1, 000 Gram-negative rod bacteria. In Proceedings of the 13th International Congress of Chemotherapy, Vienna, 1983, Vol. 2 (Spitzy, K. H. and Karrer, K., Eds), pp. 89/1-1, PS 2-5/1-3. Verlag H. Egermann, Vienna.
40. Williams, R. J., Livermore, D. M., Lindridge, M. A., Said, A. A. and Williams, J. D. (1984). Mechanisms of β-lactam resistance in British isolates of Pseudomonas aeruginosa. Journal of Medical Microbiology 17, 283-93.
41. Working Party of the British Society for Antimicrobial Chemotherapy. (1991). Standardization of inocula for sensitivity tests. Journal of Antimicrobial Chemotherapy 27, Suppl. D, 13-7.
42. Yang, Y. (1990). Chromosomal /Llactamase Expression and Antibiotic Resistance in Enterobacteria. PhD Thesis, University of London.